Autoimmunity in CD73/Ecto-5′-nucleotidase deficient mice induces renal injury

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Blume, Cornelia ^a   Felix, Agnieszka ^a   Shushakova, Nelli ^a   Gueler, Faikah ^a   Falk, Christine Susanne ^a   Haller, Hermann ^a   Schrader, Juergen ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD11B ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3; CXCL2 CHEMOKINE; ECTO 5' NUCLEOTIDASE; IMMUNOGLOBULIN G; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ADENOSINE; VASCULOTROPIN A;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CAPILLARITIS; CONTROLLED STUDY; CREATININE CLEARANCE; ENDOTHELIUM; ENZYME DEFICIENCY; GEL ELECTROPHORESIS; GLOMERULITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; INTERSTITIUM; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PERITUBULAR CAPILLARITIS; PHENOTYPE; PODOCYTE; PROTEIN BLOOD LEVEL; PROTEINURIA; UPREGULATION; WILD TYPE; ACUTE KIDNEY FAILURE; ANIMAL; BLOOD; CAPILLARY; CELL COUNT; ENDOTHELIUM CELL; IMMUNOLOGY; MESANGIUM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

5'-NUCLEOTIDASE; ACUTE KIDNEY INJURY; ADENOSINE; ANIMALS; AUTOIMMUNITY; CAPILLARIES; CELL COUNT; CHEMOKINE CXCL2; COMPLEMENT C3; ENDOTHELIAL CELLS; IMMUNOGLOBULIN G; INTERLEUKIN-18; MALE; MESANGIAL CELLS; MICE; PHENOTYPE; PODOCYTES; PROTEINURIA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861616479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037100     Document Type: Article

References (38)

1. Atkinson B, Dwyer K, Enjyoji K, Robson SC, (2006) Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis 36: 217-222.
2. Colgan SP, Eltzschig HK, Eckle T, Thompson LF, (2006) Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2: 351-360.
3. Jackson EK, Raghvendra DK, (2006) The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66: 571-599.
4. Zimmermann H, (1992) 5'-Nucleotidase: molecular structure and functional aspects (1992) Biochem J 285 (Pt 2): 345-365.
5. Thompson LF, Eltzschig HK, Ibla JC, Van De Wiele CJ, Resta R, et al. (2004) Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia. J Exp Med 2004 1395-1405 pp. 1395-1405.
6. Volmer JB, Thompson LF, Blackburn MR, (2006) Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 176: 4449-4458.
7. Koszalka P, Ozuyaman B, Huo YQ, Zernecke A, Flogel U, et al. (2004) Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circulation Research 95: 814-821.
8. Zernecke A, Ozuyaman B, Bidzhekov K, Fraemohs L, Liehn EA, et al. (2005) Cd73/ecto-5'-nucleotidase protects against vascular inflammation, monocyte recruitment and neointima formation. Circulation 112: U370.
9. Vallon V, Muhlbauer B, Osswald H, (2006) Adenosine and kidney function Physiol Rev 86: 901-940.
10. Grenz A, Osswald H, Eckle T, Yang D, Zhang H, et al. (2008) The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med 5: e137.
11. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J, (2001) International Union of Pharmacology XXV Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
12. Jacobson KA, Gao ZG, (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5: 247-264.
13. Le Hir M, Kaissling B, (1993) Distribution and regulation of renal ecto-5'-nucleotidase: implications for physiological functions of adenosine. Am J Physiol 264: F377-F387.
14. Ozuyaman B, Ding ZP, Buchheiser A, Koszalka P, Braun N, et al. (2006) Adenosine produced via the CD73/ecto-5'-nucleotidase pathway has no impact on erythropoietin production but is associated with reduced kidney weight. Pflugers Archiv-European Journal of Physiology 452: 324-331.
15. Castrop H, Huang Y, Hashimoto S, Mizel D, Hansen P, et al. (2004) Impairment of tubuloglomerular feedback regulation of GFR in ecto-5'-nucleotidase/CD73-deficient mice. J Clin Invest 114: 634-642.
16. Huang DY, Vallon V, Zimmermann H, Koszalka P, Schrader J, et al. (2006) Ecto-5'-nucleotidase (cd73)-dependent and-independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. American Journal of Physiology-Renal Physiology 291: F282-F288.
17. Hashimoto S, Huang Y, Briggs J, Schnermann J, (2006) Reduced autoregulatory effectiveness in adenosine 1 receptor-deficient mice. Am J Physiol Renal Physiol 290: F888-F891.
18. Bell TD, Luo Z, Welch WJ, (2010) Glomerular tubular balance is suppressed in adenosine type 1 receptor-deficient mice Am J Physiol Renal Physiol 299: 1158-1163.
19. Awad AS, Huang L, Ye H, Duong ET, Bolton WK, et al. (2006) Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy. Am J Physiol Renal Physiol 290: F828-F837.
20. Awad AS, Rouse M, Liu L, Vergis AL, Rosin DL, et al. (2008) Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol 19: 59-68.
21. Zhang L, Yang N, Wang S, Huang B, Li F, et al. (2011) Adenosine 2A receptor is protective against renal injury in MRL/lpr mice. Lupus 20: 667-77.
22. El Nahas AM, Bassett AH, Cope GH, Le Carpentier JE, (1991) Role of growth hormone in the development of experimental renal scarring. Kidney Int. 40: 29-34.
23. Jalkanen S, Salmi M, (2008) VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler Thromb Vasc Biol 28: 18-26.
24. Hasegawa T, Bouïs D, Liao H, Visovatti SH, Pinsky DJ, (2008) Ecto-5′nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res 103: 1410-1421.
25. Bates DO, (2010) Vascular endothelial growth factors and vascular permeability Cardiovasc Res. 15; 87 (2): 262-271.
26. Linnemann C, Schildberg FA, Schurich A, Diehl L, Hegenbarth SI, et al. (2009) Adenosine regulates CD8 T-cell-priming by inhibition of membrane-proximal T-cell receptor signaling. Immunology 128: e728-37.
27. Nakav S, Naamani O, Chaimovitz C, Shaked G, Czeiger D, et al. (2010) Regulation of adenosine system at the onset of peritonitis. Nephrol. Dial Transplant 25: 931-939.
28. Sitkovsky M, Lukashek D, Deaglio S, Dwyer K, Rbson SC, et al. (2008) Adenosine A2A receptor antagonist: Blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol 153: 457-464.
29. Romio M, Reinbeck B, Bongardt S, Hüls S, Burghoff, et al. (2011) Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells. Am J Physiol Cell Physiol. 301 (2): C530-9.
30. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, et al. (2006) Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006 Nov 7; 114 (19): 2056-64.
31. Zhang H, Hile KL, Asanuma H, Vanderbrink B, Franke El, et al. (2008) IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism. Am J Physiol Renal Physiol 301: 171-178.
32. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA, (2000) ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 15: 165: 4615-4623.
33. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C, et al. (2006) ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine dependent endothelial cell function. Circ Res 99: 1100-1108.
34. Wong CW, Christen T, Roth I, Chadjichristos CE, Derouette JP, et al. (2006) Connexin37 protects against atherosclerosis by regulating monocyte adhesion. Nat Med 12: 950-954.
35. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, et al. (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1: ra6.
36. Boraschi D, Dinarello CA, (2006) IL-18 in autoimmunity (Review). Eur Cytokine Netw. 17: 224-252.
37. Thompson LF, Takedachi M, Ebisuo Y, Tanaka T, Miyasaka M, et al. (2008) Regulation of leukocyte migration across endothelial barriers by ECTO-5′-nucleotidase-generated adenosine. Nucleosides Nucleotides Nucleic Acids 27: 755-760.
38. Nemeth ZH, Lutz CS, Csoka B, Deitch EA, Leibovich SJ, et al. (2005) Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J Immunol 175: 8260-8270.